wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34016480-1DFBBD36-C23D-4FCB-A78C-B768026C80FC
Q34016480-1DFBBD36-C23D-4FCB-A78C-B768026C80FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34016480-1DFBBD36-C23D-4FCB-A78C-B768026C80FC
Current Approaches and Emerging Directions in HER2-resistant Breast Cancer.
P2860
Q34016480-1DFBBD36-C23D-4FCB-A78C-B768026C80FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34016480-1DFBBD36-C23D-4FCB-A78C-B768026C80FC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
127fe2f947a4b1108b5ff8cf3d8118d76f31fce1
P2860
A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer.